(WRB) W. R. Berkley - Overview
Sector: Financial Services | Industry: Insurance - Property & Casualty | Exchange: NYSE (USA) | Market Cap: 25.598m USD | Total Return: -4.7% in 12m
Industry Rotation: +12.1
Avg Turnover: 121M
EPS Trend: 0.0%
Qual. Beats: 1
Rev. Trend: 95.7%
Qual. Beats: 0
Warnings
Choppy
Tailwinds
No distinct edge detected
W. R. Berkley Corporation is a global insurance holding company specializing in commercial lines, excess and surplus (E&S) insurance, and reinsurance. The firm operates through two primary segments: Insurance, which covers a vast array of specialty risks ranging from cyber and professional liability to workers compensation, and Reinsurance & Monoline Excess, which provides treaty and facultative solutions.
As a prominent player in the E&S market, the company focuses on complex or non-standard risks that traditional admitted insurers often decline to cover. This decentralized business model allows individual operating units to maintain deep expertise in specific niches, such as life sciences, energy, and marine risks.
The property and casualty sector generally relies on disciplined underwriting and investment income from premiums to drive profitability. Investors can further explore the companys historical performance and valuation metrics on ValueRay. Founded in 1967 and headquartered in Greenwich, Connecticut, the company maintains a significant presence in the Lloyds marketplace and provides diverse risk management services.
- Positive pricing trends in commercial casualty lines drive premium growth
- Rising interest rates enhance investment income from fixed-income portfolios
- Underwriting discipline in excess and surplus lines maintains low combined ratios
- Severity of catastrophe losses impacts quarterly Reinsurance segment profitability
- Inflationary pressure on medical and social litigation costs increases loss reserves
| Net Income: 1.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA -1.12 > 1.0 |
| NWC/Revenue: 68.99% < 20% (prev 68.33%; Δ 0.66% < -1%) |
| CFO/TA 0.08 > 3% & CFO 3.52b > Net Income 1.88b |
| Net Debt (-26.08b) to EBITDA (2.46b): -10.60 < 3 |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (394.8m) vs 12m ago -1.26% < -2% |
| Gross Margin: 26.14% > 18% (prev 0.22%; Δ 2.59k% > 0.5%) |
| Asset Turnover: 34.66% > 50% (prev 33.69%; Δ 0.97% > 0%) |
| Interest Coverage Ratio: 9.72 > 6 (EBITDA TTM 2.46b / Interest Expense TTM 126.9m) |
| A: 0.23 (Total Current Assets 37.07b - Total Current Liabilities 26.83b) / Total Assets 44.32b |
| B: 0.31 (Retained Earnings 13.83b / Total Assets 44.32b) |
| C: 0.03 (EBIT TTM 1.23b / Avg Total Assets 42.83b) |
| D: 0.39 (Book Value of Equity 13.38b / Total Liabilities 34.56b) |
| Altman-Z'' Score: 3.13 = A |
| DSRI: 0.91 (Receivables 7.28b/7.48b, Revenue 14.85b/13.93b) |
| GMI: 0.86 (GM 26.14% / 22.45%) |
| AQI: 0.97 (AQ_t 0.15 / AQ_t-1 0.16) |
| SGI: 1.07 (Revenue 14.85b / 13.93b) |
| TATA: -0.04 (NI 1.88b - CFO 3.52b) / TA 44.32b) |
| Beneish M-Score: -3.24 (Cap -4..+1) = AA |
Over the past week, the price has changed by +2.94%, over one month by +3.50%, over three months by -2.46% and over the past year by -4.70%.
- StrongBuy: 5
- Buy: 1
- Hold: 8
- Sell: 2
- StrongSell: 0
| Analysts Target Price | 67.4 | -1.7% |
P/E Forward = 14.2248
P/S = 1.7237
P/B = 2.5105
P/EG = 3.8423
Revenue TTM = 14.85b USD
EBIT TTM = 1.23b USD
EBITDA TTM = 2.46b USD
Long Term Debt = 2.84b USD (from longTermDebt, last quarter)
Short Term Debt = 61.5m USD (from shortTermDebt, last fiscal year)
Debt = 2.84b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -26.08b USD (recalculated: Debt 2.84b - CCE 28.92b)
Enterprise Value = 25.60b USD (floored to Market Cap, CCE > MCap+Debt)
Interest Coverage Ratio = 9.72 (Ebit TTM 1.23b / Interest Expense TTM 126.9m)
EV/FCF = 7.60x (Enterprise Value 25.60b / FCF TTM 3.37b)
FCF Yield = 13.17% (FCF TTM 3.37b / Enterprise Value 25.60b)
FCF Margin = 22.70% (FCF TTM 3.37b / Revenue TTM 14.85b)
Net Margin = 12.64% (Net Income TTM 1.88b / Revenue TTM 14.85b)
Gross Margin = 26.14% ((Revenue TTM 14.85b - Cost of Revenue TTM 10.97b) / Revenue TTM)
Gross Margin QoQ = 47.51% (prev 20.58%)
Tobins Q-Ratio = 0.58 (Enterprise Value 25.60b / Total Assets 44.32b)
Interest Expense / Debt = 1.12% (Interest Expense 31.7m / Debt 2.84b)
Taxrate = 16.32% (100.5m / 616.1m)
NOPAT = 1.03b (EBIT 1.23b * (1 - 16.32%))
Current Ratio = 1.38 (Total Current Assets 37.07b / Total Current Liabilities 26.83b)
Debt / Equity = 0.29 (Debt 2.84b / totalStockholderEquity, last quarter 9.74b)
Debt / EBITDA = -10.60 (Net Debt -26.08b / EBITDA 2.46b)
Debt / FCF = -7.74 (Net Debt -26.08b / FCF TTM 3.37b)
Total Stockholder Equity = 9.63b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.38% (Net Income 1.88b / Total Assets 44.32b)
RoE = 19.48% (Net Income TTM 1.88b / Total Stockholder Equity 9.63b)
RoCE = 9.89% (EBIT 1.23b / Capital Employed (Equity 9.63b + L.T.Debt 2.84b))
RoIC = 8.28% (NOPAT 1.03b / Invested Capital 12.47b)
WACC = 5.71% (E(25.60b)/V(28.44b) * Re(6.24%) + D(2.84b)/V(28.44b) * Rd(1.12%) * (1-Tc(0.16)))
Discount Rate = 6.24% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.92%
Shares (quarterly) Correlation: -91.11 | Cagr: -1.29%
[DCF] Terminal Value 87.44% ; FCFF base≈3.47b ; Y1≈3.90b ; Y5≈5.26b
[DCF] Fair Price = 484.6 (EV 154.33b - Net Debt -26.08b = Equity 180.41b / Shares 372.3m; r=6.0% [WACC]; 5y FCF grow 14.72% → 3.0% )
EPS Correlation: 0.05 | EPS CAGR: 4.05% | SUE: 2.10 | # QB: 1
Revenue Correlation: 95.73 | Revenue CAGR: 10.78% | SUE: 0.53 | # QB: 0
EPS current Quarter (2026-06-30): EPS=1.09 | Chg30d=-0.89% | Revisions=-26% | Analysts=16
EPS next Quarter (2026-09-30): EPS=1.09 | Chg30d=-0.24% | Revisions=+0% | Analysts=15
EPS current Year (2026-12-31): EPS=4.68 | Chg30d=+3.25% | Revisions=+70% | GrowthEPS=+8.0% | GrowthRev=+3.4%
EPS next Year (2027-12-31): EPS=4.83 | Chg30d=+0.05% | Revisions=-10% | GrowthEPS=+3.4% | GrowthRev=+4.6%
[Analyst] Revisions Ratio: +70%